Medication-taking Preferences & Practices of Patients With Chronic Conditions

Sponsor
Washington State University (Other)
Overall Status
Unknown status
CT.gov ID
NCT01614353
Collaborator
Providence Medical Research Center (Other)
30
2
13
15
1.2

Study Details

Study Description

Brief Summary

"Patients can easily be overwhelmed, confused and many times don't fully understand their need for new medications, or when the dosages are to be administered" (patient research partner quote). The long-term goal of this study is to refine medication science by developing patient-centered assessment, monitoring and management guidelines for patients and health professionals. The objective is to advance knowledge about the medication-taking perspectives, experiences, and behaviors of older adults with multiple chronic medical conditions (MCMC) to inform future research related to patient-centered medication prescribing, monitoring and management. This pilot study addresses the following PCORI interest area: "evaluating methods that can be used to assess the patient perspective when researching behaviors and choices within the patient's control that may influence outcomes." The rationale that underlies the proposed study is that medication-taking practices are wholly within patients' control, and are foundational to reducing complications and improving outcomes for those with MCMC. To meet the overall objective of this application, the following specific aims will be pursued: 1) identify perceptions and behaviors surrounding the medication-taking process of older adults with MCMC; and 2) generate an interpretation of the meaning of medication-taking among older adults with MCMC. To achieve these aims, data will be obtained in "real time" from patients (N=30) receiving a new prescription using smart phone technology. The smart phones will include prompts to help participants record thoughts about medication use throughout the day for 30 days. Findings from electronic diaries will be logged, analyzed and qualitatively analyzed. Some patients (n=15) will provide in-depth hermeneutic interviews to provide rich descriptions and interpretive commentary about the experience of receiving a new medication prescription. The objective is to uncover previously unidentified areas of common experience in older persons with multiple chronic conditions who have received a new prescription. Common experiences and patterns of influences, that are often surprising or unexpected, will be categorized and assessed. The expected outcomes of this pilot study are improved knowledge of medication-taking perceptions, experiences, and practices of older adults with MCMC-knowledge that is critical to advance patient-centered medication science.

Condition or Disease Intervention/Treatment Phase
  • Other: Electronic Diaries
  • Other: Hermeneutic Interviews

Study Design

Study Type:
Observational
Anticipated Enrollment :
30 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Medication-taking Preferences & Practices of Patients With Chronic Conditions
Study Start Date :
Oct 1, 2012
Anticipated Primary Completion Date :
Oct 1, 2013
Anticipated Study Completion Date :
Nov 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Study Cohort

All participants (N=30) will be asked to identify perceptions and behaviors surrounding the medication-taking process using technology-assisted prompts and recordings. Half (n=15) of the participants will participate in two hermeneutic interviews using an interpretive phenomenological approach to generate an interpretation of the meaning of medication taking.

Other: Electronic Diaries
Participants (N=30) will maintain electronic diaries to record spontaneous thoughts and perceptions regarding the use of a newly prescribed drug over 30 days.

Other: Hermeneutic Interviews
Half of the enrolled participants (n=15) will participate in 2 hermeneutic interviews conducted in an interpretive phenomonological approach to generate an interpretation of the meaning of medication taking.

Outcome Measures

Primary Outcome Measures

  1. Identify perceptions and behaviors surrounding the medication-taking process of older adults with MCMC. [Daily electronic diaries for a duration of 30 days]

    Data will be obtained in "real time" in that patients will audio record thoughts as they arise in the course of each day using an electronic device, over 30 consecutive days, and will answer questions related to medication use. Findings from end of day prompts will be logged using tables that compare participant demographic characteristics, whether or not the new medication or all prescribed medication was taken, and self-assessed level of wellness.

  2. Generate an interpretation of the meaning of medication taking among older adults with MCMC. [2 Interviews: 1 at enrollment and 1 at 30 days]

    In-depth hermeneutic interviews and interpretive phenomenological analyses will be conducted for 15 of the 30 enrolled participants. Patterns and themes that capture common experiences revealed in these data provide language for further investigation and new discussion in areas that have been studied traditionally. Such findings are the characteristic "phenomenological contribution" of qualitative research. Interpretive commentary in the context of social and cultural evidence and extant literature on medication use will be generated.

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 60 years of age or older

  • Diagnosis of at least 3 chronic medical conditions

  • Receiving 5 or more medications

  • Receipt of a new prescription medication at enrollment

  • Ability to speak English

Exclusion Criteria:
  • Any individual that does not meet the 5 inclusion criteria listed above

Contacts and Locations

Locations

Site City State Country Postal Code
1 Providence Medical Research Center Spokane Washington United States 99201-4813
2 Washington State University Spokane Washington United States 99210-1495

Sponsors and Collaborators

  • Washington State University
  • Providence Medical Research Center

Investigators

  • Principal Investigator: Joshua Neumiller, PharmD, Washington State University
  • Principal Investigator: Roxanne Vandermause, PhD, Washington State University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Roxanne Vandermause, Associate Professor, Washington State University
ClinicalTrials.gov Identifier:
NCT01614353
Other Study ID Numbers:
  • PI-12-001
First Posted:
Jun 7, 2012
Last Update Posted:
Dec 21, 2012
Last Verified:
Dec 1, 2012
Keywords provided by Roxanne Vandermause, Associate Professor, Washington State University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 21, 2012